Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation

Lancet Oncol. 2005 May;6(5):344-6. doi: 10.1016/S1470-2045(05)70171-6.

Authors

Robert F Wynn¹, Peter D Arkwright, Tanzina Haque, Maged I Gharib, Gwen Wilkie, Marie Morton-Jones, Dorothy H Crawford

Affiliation

¹ Royal Manchester Children's Hospital, University of Manchester, UK.

PMID: 15863383
DOI: 10.1016/S1470-2045(05)70171-6

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adoptive Transfer*
Central Nervous System Neoplasms / therapy
Central Nervous System Neoplasms / virology*
Child
Epstein-Barr Virus Infections / complications*
Epstein-Barr Virus Infections / therapy
Female
Humans
Lymphoma, B-Cell / therapy
Lymphoma, B-Cell / virology*
Magnetic Resonance Imaging
Stem Cell Transplantation*
T-Lymphocytes, Cytotoxic*